Retroviral vectors for gene transfer experiments have their limitations — hence the attraction of using other viral vehicles to administer genes directly to affected organs.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Verma, I. Sci. Am. 263, 68–84 (1990).
Anderson, W.F. Science 256, 808–813 (1992).
Miller, A. D. Nature 357, 455–460 (1992).
Jaffe, H.A. Nature Genet. 1, 372–384 (1992).
Wolfe, J.H., Deshmane, S.L. & Fraser, N.W. Nature Genet 1, 379–384 (1992).
Rosenfeld, M.A. Cell 68, 143–155 (1992).
Lemarchand, P. et al. Proc. natn. Acad. Sci. U.S.A. 89, 6482–6486 (1992).
Stratford-Perricaudet, L.D. et al. Hum. Gene Ther. 1, 241–256 (1990).
Travis, G.M. Neuron 9, 113–119 (1992).
Rights and permissions
About this article
Cite this article
Davies, K. Moving straight to the target. Nature 358, 519 (1992). https://doi.org/10.1038/358519a0
Issue date:
DOI: https://doi.org/10.1038/358519a0
